Shi, Lizheng; Yang, Heidi; Cheng, Gang; Meng, Qingyue - In: PharmacoEconomics 32 (2014) 3, pp. 257-264
The cost escalations in PEs and health expenditures were concurrent with GDP growth. TPE has been the major source of financial burden for patients. Even though the rapid growth in China’s economy may ameliorate the overall TPE burden, control of PEs is still a key for successful health system...